Citrus suavissima

Citrus suavissima, commonly known as sweet orange, is a traditional plant with origins in Southeast Asia. While its use has not been extensively documented in traditional medicine practices, studies have shown promising results. Scientific evidence indicates that enzymatically modified pectins from the peel of Citrus suavissima can inhibit HeLa cell proliferation, though the strength of this finding remains to be further validated. Additionally, a study identified 487 differentially expressed proteins associated with sporopollenin biosynthesis and pollen exine formation in a seedless mutant compared to the wild type. The juice of Citrus suavissima has shown tendencies to inhibit CYP1A2 and CYP2C19 enzymes while inducing CYP2C9, but did not significantly influence CYP2D6. Naringin, a compound found in citrus fruits, was noted for its potential ability to inhibit proinflammatory cytokine expression and bind to ACE2 receptors. Safety records for Citrus suavissima show no major issues reported, suggesting that it may be generally safe when used as intended. However, given the lack of extensive traditional use data, caution should still be exercised. There are currently no recorded drug interactions with this plant, but further research is needed to fully understand its potential effects and interactions.

Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.